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ABSTRACT 
 
Objective: Pregnancy is a period of considerable change in blood pressure, with an early 
pregnancy decrease followed by a late pregnancy rise. High blood pressure in pregnancy is 
associated with adverse perinatal outcomes for the mother and offspring. We aimed to define 
normal ranges of blood pressure across gestation. 
Methods: We used repeated antenatal blood pressure measurements (median (interquartile 
range) 10 (9, 11) per woman) for 10,327 women. Multilevel models were used to derive 
longitudinal reference ranges for systolic (SBP) and diastolic (DBP) blood pressure from 12-
40 weeks gestation for the whole cohort, for women with normal pregnancies (without 
essential hypertension or preeclampsia who delivered an appropriate-size-for-gestational age 
infant at term) and for subgroups of normal pregnancies defined by different levels of 
maternal pre-pregnancy BMI, smoking and parity. 
Results: In normal pregnancies the mean (95% reference range) SBP and DBP for 
nulliparous women at 12 weeks gestation were 112.1 (88.6, 135.5) and 65.4 (48.9, 81.9) 
mmHg, and at 37 weeks were 116.0 (92.3, 139.7) and 70.0 (52.2, 87.9) mmHg respectively. 
For every additional 10 mmHg of blood pressure at 12 weeks, normal ranges were 2-3 mmHg 
higher across gestation. Reference ranges for multiparous women were 1-2 mmHg lower 
throughout pregnancy. Stratified reference ranges were higher for women in higher pre-
pregnancy BMI categories, and lower for smokers than for non-smokers throughout 
pregnancy.  
Conclusion: Normal ranges for blood pressure vary with gestation age and by maternal 
subgroups. Whole population and stratified normograms could be used as a reference to 
identify abnormal trajectories. 
Keywords: ALSPAC; blood pressure; longitudinal; pregnancy; reference range 
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Introduction 
 
Around 10% of women experience some form of hypertension during pregnancy,[1, 2] which 
may be pre-existing or pregnancy-induced. These pregnancies carry a greater risk of a range 
of adverse perinatal outcomes, including maternal and fetal death,[3-5] intrauterine growth 
restriction of the infant and preterm birth.[6-8] However, pregnancy is a period of substantial 
change in blood pressure, with an early pregnancy decrease followed by a steep rise in the 
latter half of pregnancy.[9, 10] There is evidence that, even among women without pre-
existing hypertension or preeclampsia,[11]  a greater increase in blood pressure, and the 
maximum level reached, are also associated with reduced fetal growth.[11, 12]  
 
Furthermore, the early-pregnancy level and the average change in blood pressure have been 
found to differ by maternal pre-pregnancy BMI, smoking and parity,[10, 13, 14] even among 
women who then experienced a healthy birth outcome.[10] This would imply that different 
trajectories of blood pressure may be healthy for different subgroups of women. However, 
differences in blood pressure trajectories by maternal age and education were much 
smaller.[10] It is also plausible that the normal trajectory may depend on the initial level of 
blood pressure, since a greater increase is likely to be tolerable for a woman who begins 
pregnancy with a relatively low blood pressure. Establishing blood pressure reference ranges 
across pregnancy for different subgroups of women, who do not experience adverse health 
outcomes, may provide important information about what is normal at different gestational 
ages for different women. These normal ranges could be useful for the identification of 
women whose blood pressure is deviating from a healthy trajectory before they cross the high 
blood pressure threshold, and thus lead to earlier detection of women at risk. Despite the clear 
importance of blood pressure in pregnancy, to our knowledge, there are currently no normal 
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reference ranges to aid clinical interpretation of the repeat antenatal monitoring which is 
routinely carried out. 
 
Our aim was to develop reference ranges for systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) across pregnancy, firstly for all women regardless of pregnancy 
outcome and then for women who have healthy term pregnancies (without essential 
hypertension or preeclampsia, resulting in a live birth of an appropriate-size-for-gestational-
age baby) in a large population-based prospective cohort. We also divided the group of 
women who had healthy term pregnancies into a low-risk and a high-risk group based on 
maternal characteristics and fitted reference ranges that were stratified by parity, BMI, 
smoking and early-pregnancy blood pressure in order to allow for a different normal 
trajectory of blood pressure change for different subgroups of women. 
 
Methods 
 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective cohort 
study investigating the health and development of children. The study has been described in 
full elsewhere[15] and the study website contains details of available data at 
http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary. In brief, pregnant 
women with an expected delivery date between 1
st
 April 1991 and 31
st
 December 1992 living 
in a defined area of Avon, South West England, were eligible for recruitment.  Ethical 
approval for the study was obtained from the ALSPAC Law and Ethics Committee and from 
the National Health Service (NHS) local ethics committee. In total 14,541 women were 
enrolled and 13,678 had a singleton pregnancy resulting in a live birth. We excluded multiple 
pregnancies since these would have different patterns of blood pressure change and there 
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were insufficient numbers to study these in detail.  13,461 of the women had data abstracted 
from obstetric records and 13,000 had at least one blood pressure measurement during 
pregnancy. Of these, 10327 had complete data on all maternal characteristics. 
 
 
Obstetric measurements 
All SBP and DBP measurements which were taken as part of routine antenatal care by 
midwives or obstetricians were abstracted from the women’s obstetric records by six trained 
research midwives. There was no between-midwife variation in mean values of the data 
abstracted and error rates were consistently <1% in repeated data entry checks. These were 
single blood pressure measurements taken in the seated position using the appropriate cuff 
size, using Korotkoff phase V for DBP. The gestational age of measurement was derived 
from the date of measurement and the expected delivery date. Gestational age at delivery was 
derived from the expected delivery date and the date of birth. For most women the expected 
delivery date was based on the last menstrual period date, while for a small proportion this 
estimate was updated following an ultrasound scan. In the data abstracted from the clinical 
records it was not recorded which few women had a scan or had their gestational age 
adjusted.   
 
Birth size 
The child’s birthweight was obtained from the birth notification. We defined small-for-
gestational age (SGA) as below the 10
th
 percentile of birthweight for gestational age and 
large-for-gestational age (LGA) as above the 90
th
 percentile of birthweight for gestational age 
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within this cohort by regressing birthweight on gestational age and extracting the residuals.  
 
Hypertension and diabetes before and during pregnancy 
Using all available blood pressure measurements, preeclampsia was defined using the 
International Society for the Study of Hypertension in Pregnancy (ISSHP) definition as SBP 
≥ 140 mmHg and/or DBP ≥ 90 mmHg as well as proteinuria of 1+ or more on urine dipstick 
testing on two occasions after 20 weeks gestation in a woman who was not known to be 
hypertensive prior to pregnancy.[16] Women who responded to a questionnaire administered 
during pregnancy that they had previously had hypertension outside of pregnancy were 
considered to have essential hypertension. Women who responded that they had previously 
had diabetes outside of pregnancy were classed as having existing diabetes, and for those 
without existing diabetes, any diagnosis of gestational diabetes was obtained from obstetric 
records.  
 
Other maternal characteristics 
Maternal pre-pregnancy weight, height, parity and smoking status were obtained from 
questionnaires administered during pregnancy. Pre-pregnancy BMI was calculated as 
weight(kg)/ height(m)
2
 and classed according to World Health Organisation definitions of 
underweight (<18.5kg/m
2
), normal (18.5-24.9kg/m
2
), overweight (25.0-29.9kg/m
2
) and obese 
(≥30.0kg/m2). A questionnaire at 18 weeks gestation asked about smoking status, which was 
categorised as: “never during pregnancy”; “pre-pregnancy/first trimester” for women who 
smoked immediately prior to pregnancy or in the first 3 months and then stopped; or 
“throughout” for women who continued to smoke after the first 3 months. 
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Definition of normal pregnancy 
To restrict to normal pregnancies we excluded 515 (5.0%) women who delivered preterm 
(<37 weeks gestation), 937 (9.1%) who had a SGA offspring, 1,040 (10.1%) who had a LGA 
offspring, 369 (3.6%) with pre-existing hypertension, 213 (2.1%) who developed 
preeclampsia, 38 (0.4%) with existing diabetes and 46 (0.4%) who developed gestational 
diabetes (total excluded = 2,823). We did not exclude women who had gestational 
hypertension, as this would have removed the top end of the blood pressure distribution and 
biased reference ranges downwards. After these exclusions there remained 7,504 women who 
had a normal pregnancy. 
 
Statistical Analysis 
To develop longitudinal reference ranges for SBP and DBP across gestation we used 
multilevel models with two levels: measurement occasions (level 1) within women (level 2). 
These models take into account that the repeated measurements of blood pressure within 
individuals are not independent, and allow for varying numbers and timings of measurements 
between women under a missing at random assumption.[17, 18]  
 
Separate multilevel models were fitted with SBP and DBP as the outcome respectively and 
each had gestational age as the exposure, assuming normal variation in the population at each 
gestational age. Restricted cubic splines with knots at 11, 18, 30, 36 and 40 weeks gestation 
were used to describe the shape of the blood pressure trajectory over gestation. Full 
information is provided in online supplemental material (including the choice of knots). The 
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baseline gestational age was set at 12 weeks as this was the median time of the first antenatal 
measurement. In addition to gestational age the models included other explanatory variables 
as described below, or were fitted separately on certain sub-groups of women to allow for 
complexity in their trajectories. 95% reference ranges for SBP and DBP from 12 to 40 weeks 
gestation were then estimated from each fitted model.  
 
We first fitted reference ranges for all women who had complete data on all maternal 
characteristics, regardless of pregnancy outcome. We then restricted to women who had a 
normal pregnancy (see definition above). Finally, we divided the women who had a normal 
pregnancy into subgroups and fitted normal reference ranges for the different subgroups. 
 
The subgroups of interest were defined by the cross-classification of BMI and smoking 
status. The “low-risk” group comprised those who had normal pre-pregnancy BMI and did 
not smoke either immediately prior to or during pregnancy. The “high-risk” group included 
women who were overweight/obese and who smoked either immediately prior to pregnancy 
or in the first trimester only or who smoked throughout pregnancy. Further reference ranges 
were produced by pre-pregnancy BMI category (including only those who never smoked) and 
by smoking status (including only those with a normal pre-pregnancy BMI). In order to 
predict blood pressure trajectories for the entire duration of pregnancy from a single blood 
pressure measure at 12 weeks, as would be available in a clinical setting, reference ranges 
conditional on such possible values were developed for the low-risk group (see supplemental 
material).[19] In each of these analyses, separate models were fitted for nulliparous and 
multiparous women. A full list of the subgroups for whom reference ranges have been 
developed is given in Web-Table 1. 
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As a sensitivity analysis we re-fitted the reference ranges in the low-risk group as defined 
when using the customised fetal growth reference of Gardosi et al[20] to define SGA and  
LGA. Reference ranges were not meaningfully different from those presented here.  
 
We used MLwiN version 2.27 to fit the multilevel models which we ran through Stata using 
the runmlwin command.[21] Stata version 12.1 was used for all other analyses. 
 
Results 
The characteristics of women who had complete data for inclusion in reference ranges and 
those that were excluded from analysis due to missing maternal characteristic data are shown 
in Table 1. Women who were included were generally similar to those who were excluded, 
although they were slightly more likely to be underweight. Women who were included who 
had normal pregnancies had lower SBP and DBP at 12 and 37 weeks gestation and were less 
likely to be overweight/obese, less likely to be nulliparous and less likely to smoke 
throughout pregnancy than women who were considered to have an abnormal pregnancy due 
to either a medical condition (essential hypertension, preeclampsia, existing or gestational 
diabetes N=647) or an adverse perinatal outcome (preterm birth, SGA or LGA offspring; 
N=2404).  
 
Figure 1 shows the reference ranges for SBP and DBP between 12 and 40 weeks gestation for 
all women and for those women who had a normal pregnancy, by parity. The predicted 
values and 95% reference ranges at 12, 20 and 37 weeks gestation are shown in Web-Table 2. 
The reference ranges for SBP and DBP decreased until mid-pregnancy in both nulliparous 
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and multiparous women before rising until the end of pregnancy, although the decrease was 
more pronounced in multiparous women than in nulliparous women. The average timing of 
the nadir varied, occurring at 17 weeks in nulliparous women and 18 weeks in multiparous 
women in the whole cohort and also when restricting to normal pregnancies. The nadir in 
DBP occurred at around 19 weeks of gestation in nulliparous women and 20 weeks in 
multiparous women in the whole cohort and at around 20 weeks for both nulliparous and 
multiparous women when restricting to normal pregnancies. The 95% reference range for 
SBP was approximately 45-50 mmHg wide and for DBP was approximately 30-35 mmHg 
wide in the whole cohort; both widening slightly towards the end of gestation. Upper 
reference range limits were generally slightly lower across gestation in normal pregnancies 
than in the whole cohort but, as ranges were also slightly narrower, the lower reference range 
limits were similar in the whole cohort and in normal pregnancies. 
 
Reference ranges in sub-groups of normal pregnancies 
The reference ranges of SBP and DBP across gestation in the low-risk group (normal pre-
pregnancy BMI; never smoked) and in the high-risk group (overweight/obese; smoked at any 
time either immediately prior to or during pregnancy) of women who had normal pregnancies 
are shown in Figure 2. Web-Table 2 shows the predicted values and 95% reference ranges of 
SBP and DBP at 12, 20 and 37 weeks gestation. Reference ranges in the high-risk group were 
generally around 4 mmHg higher than in the low-risk group across pregnancy for both 
nulliparous and multiparous women. SBP for nulliparous women in the high-risk group did 
not show a mid-pregnancy dip, but increased throughout pregnancy. 
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Reference ranges stratified by maternal pre-pregnancy BMI are shown for nulliparous non-
smoking women in Figure 3 and for multiparous women in Web-Figure 1. For both 
nulliparous and multiparous women there was an increasing trend in the limits of the 
reference ranges with increasing pre-pregnancy BMI category at each gestational age. For 
example, for nulliparous women, upper and lower reference range limits of SBP were 
approximately 10 mmHg higher throughout pregnancy for obese compared with normal 
weight women, and for DBP were approximately 7.5-8 mmHg higher (Web-Table 2). The 
shape of the blood pressure trajectory also differed by pre-pregnancy BMI category (Web-
Figures 2 and 3), with obese women having a more distinct nadir in SBP and DBP than 
normal weight women in the nulliparous group.  
 
Reference ranges stratified by smoking during pregnancy are shown in Figure 4 for 
nulliparous normal-weight women and Web-Figure 4 for multiparous women. SBP reference 
ranges were around 0-1.5 mmHg lower across pregnancy for women who smoked throughout 
pregnancy than for non-smokers, while DBP reference ranges were around 1-2 mmHg lower 
(Web-Table 2). Those who smoked only pre-pregnancy/1
st
 trimester had 1-2 mmHg lower 
SBP and DBP reference ranges in early pregnancy than non-smokers, but this difference 
attenuated towards the end of gestation. The average SBP and DBP trajectories by smoking 
status are shown in Web-Figures 5 and 6 respectively. 
 
Figure 5 shows the predicted reference ranges of SBP and DBP across pregnancy, conditional 
on different possible levels of blood pressure at 12 weeks gestation for nulliparous women. 
The equivalent reference ranges for multiparous women are shown in Web-Figure 7. For each 
additional 10 mmHg in SBP at 12 weeks, the reference ranges for SBP were predicted to be 
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approximately 4 mmHg higher at 20 weeks and around 3 mmHg higher at 37 weeks gestation 
in both nulliparous and multiparous women (Web-Table 3). For each additional 10 mmHg in 
DBP at 12 weeks, the reference ranges for DBP were predicted to be around 3 mmHg higher 
at 20 weeks and around 2.5 mmHg higher at 37 weeks (Web-Table 3). 
 
Discussion 
We have derived reference ranges for blood pressure from 12 to 40 weeks gestation in a large 
population-based pregnancy cohort and compared these with reference ranges for women 
who had a normal pregnancy, without essential hypertension or preeclampsia, existing or 
gestational diabetes who delivered an appropriate-sized infant at term. We found that normal 
pregnancies had generally lower upper reference range limits and narrower reference ranges 
throughout pregnancy. We also observed differences in reference ranges between different 
subgroups of women with normal pregnancies based on pre-pregnancy BMI, smoking and 
parity and found that the expected normal trajectory of blood pressure differed by the blood 
pressure at the first antenatal visit (in this cohort at around 12 weeks gestation). To our 
knowledge there are no existing longitudinal reference ranges for blood pressure in normal 
pregnancy. The shape of the average trajectory of blood pressure in pregnancy as decreasing 
until mid-pregnancy followed by an increase in late-pregnancy has been well-described,[9, 
22, 23] and the addition of normal ranges to these average trajectories allows observed blood 
pressure measurements at any gestational age to be compared with expected limits.  
 
This study benefits from its large size, repeated measurements of blood pressure and detailed 
information on maternal characteristics. The blood pressure measurements were collected 
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during routine clinical practice, and thus will have greater measurement error than 
standardized measures. However, this means that the reference ranges are applicable to a 
clinical setting. The pregnancies occurred approximately 20 years ago and levels of obesity in 
the UK have increased over this period[24] while smoking prevalence has reduced.[25] 
However, the analyses are stratified by BMI and smoking and these changes are unlikely to 
have had a large effect on blood pressure levels within strata. The ALSPAC participants also 
differed slightly from the UK as a whole, being more likely to live in owner-occupied 
accommodation and to have a car and less likely to be non-white.[15] In the interests of space 
we have not presented reference ranges for all possible subgroups of women, but have 
provided examples of low and high-risk groups and demonstrated how reference ranges differ 
with each of the maternal characteristics. This approach could be extended to develop 
customised blood pressure charts for all women based on pre-pregnancy BMI, smoking, 
parity and first blood pressure measurement, however we did not have sufficient power to 
derive reference ranges for some of the smaller subgroups in the present study. The graphs 
presented here are illustrative and validation in other cohorts is required before these can be 
used in clinical practice. 
 
The differences in normal ranges between obese and normal weight women of ~8-10 mmHg 
in SBP and ~6.5-8 mmHg in DBP at each gestational age are in line with the differences in 
average trajectories found in our previous study in this cohort with weaker exclusion 
criteria,[10] in the Generation R study from the Netherlands[13] and in the US-based Omega 
Study.[26] The two studies in other cohorts, however, included women with preeclampsia, 
preterm birth and SGA or LGA offspring. The magnitude of the differences between BMI 
categories may have important implications for risk-related levels of high blood pressure for 
women of different BMIs and at different gestational ages. For example, for nulliparous 
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obese women, values of SBP over 140 mmHg were well within the 95% reference range 
across the whole of pregnancy, whereas for normal weight women the 95% reference range 
remains below 135 mmHg for much of pregnancy.  
 
Although smaller differences in blood pressure reference ranges were seen between smoking 
groups (up to 2 mmHg) they suggest that smoking status may be useful to include, along with 
pre-pregnancy BMI, in prediction models which use deviations from each woman’s expected 
blood pressure trajectory to identify high-risk pregnancies. In our previous study we found 
strong statistical evidence to support lower average blood pressure trajectories for smokers 
than for non-smokers,[10] and other cohorts have supported this finding for DBP, although 
findings relating to SBP have been conflicting.[9, 14, 27] It has been shown that blood 
pressure tracks moderately across pregnancy, with almost 50% of women remaining in the 
same third of blood pressure from the 1
st
 trimester to the 3
rd
 trimester,[23] which supports the 
differences which we found in the expected trajectories of blood pressure across pregnancy 
by blood pressure levels at 12 weeks. 
 
The diagnostic criteria for hypertensive disorders of pregnancy (HDP) use the same blood 
pressure thresholds of 140/90 mmHg across the whole gestational period between 20 weeks 
and delivery and for all women, although nulliparous women, obese women and those with 
high pre-pregnancy blood pressure are considered to be at high risk for HDP.[28] Our 
findings suggest that using different blood pressure thresholds for different maternal 
subgroups to identify women whose blood pressure has deviated from the normal trajectory 
may provide additional information about risk. Nevertheless, subgroups of women who are 
known to be at higher risk of adverse perinatal outcomes should be considered as such, even 
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with blood pressure within the normal range. Our reference ranges also show differences of 
around 5 mmHg in SBP and DBP between 20 weeks and delivery, suggesting that using 
different blood pressure thresholds at different gestational ages may improve the 
identification of women with abnormal trajectories.  
 
There has been much research in the area of fetal growth charts,[29-31] and more recently 
customised charts which are dependent on maternal characteristics.[20] Routine 
measurements of symphysis-fundal height and ultrasound scan measurements of fetal size 
may be compared against these charts and used to identify growth restricted foetuses.[32, 33] 
There may be potential for blood pressure charts in pregnancy to be used in conjunction with 
fetal growth charts to aid in the identification of pregnancies at risk of SGA infants, since 
high blood pressure and greater increases in blood pressure are associated with reduced 
offspring birthweight.[11, 12] In addition, blood pressure reference ranges may help to 
identify women who are at risk of preeclampsia and delivering preterm. We have previously 
shown in this cohort[34] and others elsewhere,[23] that the increase in blood pressure is 
steeper in preeclamptic compared with normotensive pregnancies. Thus, preeclamptic women 
would be expected to deviate from the normal pattern of change, although the potential for 
deviations from the normal trajectory to be used in prediction of adverse outcomes remains to 
be assessed. 
 
We conclude that the normal pattern of change in blood pressure across gestation, for a 
healthy term pregnancy resulting in an appropriate sized infant, differs by maternal 
subgroups. There may be potential to use whole population and stratified normal reference 
ranges such as these in screening for women with abnormal trajectories, which may be 
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indicative of potential adverse pregnancy outcomes such as preeclampsia, preterm birth and 
SGA offspring. However, the value of this will require evaluation through the development 
and validation of prediction models. 
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Table 1 Maternal characteristics of women who were excluded from analysis due to incomplete data and of women who were included by 
pregnancy type 
*
 This is the number of blood pressure measurements per woman after randomly selecting one measure per 2-week period of pregnancy for use in the multilevel 
models
 Pregnancies without 
complete data 
(N=2673) 
Pregnancies with complete data 
All (N=10327) Normal pregnancies 
(N=7504) 
Maternal medical 
condition or adverse 
pregnancy outcome 
(N=2823) 
N with 
data 
Mean (SD) or 
% 
N Mean (SD) or 
% 
N  Mean (SD) or 
% 
N Mean (SD) or 
% 
Blood pressure         
SBP at 12 weeks (mmHg) 2673 112.1 (12.77) 10327 112.1 (12.12) 7504 111.5 (11.83) 2823 113.7 (12.72) 
DBP at 12 weeks (mmHg) 2673 65.7 (9.06) 10327 65.7 (8.56) 7504 65.2 (8.30) 2823 66.8 (9.13) 
SBP at 37 weeks (mmHg) 2673 116.0 (13.21) 10327 116.0 (12.92) 7504 115.0 (12.22) 2823 118.8 (14.22) 
DBP at 37 weeks (mmHg) 2673 70.0 (10.24) 10327 69.9 (9.71) 7504 69.0 (9.06) 2823 72.4 (11.42) 
Number of measures
*
 (median (IQR)) 2673 10 (8, 11) 10327 10 (9, 11) 7504  10 (9, 12) 2823 10 (8, 11) 
Parity         
Nulliparous (%) 794 45.4 4718 45.7 3372 44.9 1346 47.7 
Multiparous (%) 954 54.6 5609 54.3 4132 55.1 1477 52.3 
Pre-pregnancy BMI         
Underweight (%) 35 7.1 514 5.0 379 5.1 135 4.8 
Normal weight (%) 351 71.2 7665 74.2 5703 76.0 1962 69.5 
Overweight (%) 77 15.6 1566 15.2 1074 14.3 492 17.4 
Obese (%) 30 6.1 582 5.6 348 4.6 234 8.3 
Smoking in pregnancy         
Never (%) 1044 55.8 7076 68.5 5176 69.0 1900 67.3 
Pre-pregnancy/1
st
 trimester (%)  309 16.5 1373 13.3 1000 13.3 373 13.2 
Throughout (%) 518 27.7 1878 18.2 1328 17.7 550 19.5 
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Figure 1 Reference ranges for systolic and diastolic blood pressure between 12 and 40 
weeks gestation in the full cohort with complete data (nulliparous N=4718; multiparous 
N=5609) and in normal pregnancies only (nulliparous N=3372;  multiparous N=4132) 
* 
 
*
 A normal pregnancy was defined as one where the woman did not have essential 
hypertension, preeclampsia, existing or gestational diabetes and delivered an appropriate-for-
gestational-age sized infant at term
24 
 
Figure 2 Reference ranges for systolic and diastolic blood pressure between 12 and 40 
weeks gestation in low-risk (nulliparous N=1832; multiparous N=2193) and high-risk 
(nulliparous N=205;  multiparous N=285) normal pregnancies
* 
 
*
 The low-risk group included women who had a normal pre-pregnancy BMI and did not 
smoke either immediately prior to or during pregnancy. The high-risk group included 
overweight or obese women who smoked either immediately prior to pregnancy, in the 1
st
 
trimester or throughout pregnancy
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Figure 3 Reference ranges for systolic and diastolic blood pressure by maternal pre-
pregnancy BMI category for nulliparous non-smokers with normal pregnancies 
(N=2270) 
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Figure 4 Reference ranges for systolic and diastolic blood pressure by maternal smoking during pregnancy for nulliparous normal-
weight women with normal pregnancies (N=2654) 
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Figure 5 Reference ranges for systolic and diastolic blood pressure in pregnancy conditional on the level of blood pressure at 12 weeks 
gestation for nulliparous normal-weight non-smoking women with normal pregnancies (N=1832)
* 
 
*
 Note that in each of the plots there is a star that corresponds to the value of SBP/DBP at 12 weeks. 
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Supplementary Methods 
 
Gestation was initially divided into two-week periods and, for women who had more than 
one blood pressure measurement available in any two-week period, one blood pressure 
measurement was selected at random per two-week period for each woman. This was to 
prevent women who had many measurements during pregnancy, who may represent less-
healthy women, having a disproportionately high influence on the multilevel models. 
 
Separate multilevel models with systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) as outcomes were used to model the trajectory of change in SBP and DBP with 
gestational age. Several possible parameterisations of the shape of the curve were considered 
and the fit compared using the BIC and the difference between each individual’s predicted 
values and their actual blood pressure measurements across gestation. These included: 
fractional polynomial curves with up to two powers of gestational age, using the set of 
powers (-2, -1, -0.5, 0, 0.5, 1, 2, 3);[1] linear splines with up to 3 knots and restricted cubic 
splines with up to 5 knots. Linear splines have been fitted previously to these data, and the 
best-fitting knot point locations were found to be at 18, 30 and 36 weeks gestation.[2] The 
restricted cubic spline with 5 knots were fitted using knots selected by the percentile method 
of Harrell[3] and also using the 3 knots found to be optimum for the linear splines (18, 30 and 
36 weeks) for the middle 3 knots and the 5
th
 and 95
th
 percentiles of the data for the outer 2 
knots (11 and 40 weeks). The fractional polynomial curve had a poorer fit compared with the 
linear or cubic splines. Linear splines and restricted cubic spline models with knots at 18, 30 
and 36, and 11, 18, 30, 36 and 40 weeks respectively had the best fit to the data and fitted 
similarly. However, due to the smooth nature of the restricted cubic spline, reflecting the 
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expected smooth change in blood pressure, this was selected and used for the normal 
reference ranges. 
 
The models had two levels: measurement occasions (level1) within women (level2), 
reflecting the clustering of the data. Individual-level random effects were fitted for the 
intercept and for each of the cubic spline parameters, allowing the initial level and shape of 
the trajectory of change in blood pressure across gestation to vary between women. We 
allowed the within-individual variation in blood pressure to vary with gestational age as there 
was evidence of increasing variation in blood pressure as gestational age increased. Thus the 
model without covariates included took the following form: 
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where, yij is the value of the i
th
 SBP or DBP measurement on the j
th
 individual, β0-β4 describe 
the average trajectory of change, u0j-u4j describe how the j
th
 individual’s trajectory of SBP or 
DBP deviates from the average and GAij is the gestational age in weeks of the i
th
 
measurement on the j
th
 individual. It is centred at 12 weeks in order to set the intercept, β0, to 
represent blood pressure at 12 weeks. The e0ij and e1ij terms describe the deviation of the i
th
 
measurement of SBP or DBP on the j
th
 individual from the individual’s trajectory. These are 
residual error terms. 
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The splines are defined as:[3] 
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The variance of the individual blood pressure measurements at each gestational age was 
calculated as the sum of the between-individual-variance and the within-individual 
variance.[4] 
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where, for example, spline1g represents the value of the first cubic spline at gestational age g. 
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Therefore, the value of the 95
th 
percentile for the reference range at gestational age, g, is:  
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This gives the reference range for observed measures of blood pressure, rather than for an 
individual’s underlying blood pressure trajectory, as it includes both the between-individual 
and within-individual variances of blood pressure. 
The fit of the model-predicted SBP and DBP across gestation to the observed SBP and DBP 
values in the nulliparous “low-risk” group (normal pre-pregnancy BMI and non-smoker) is 
shown in Tables 1 and 2 respectively, and in the multiparous “low-risk” group is shown in 
Tables 3 and 4. 90% of the predictions for SBP in each gestational period were generally 
within around 14 mmHg of the observed SBP values and 90% of predictions for DBP in each 
gestational period were generally within around 11 mmHg of the observed DBP values.  
To produce reference ranges by pre-pregnancy BMI category, BMI was entered into the 
multilevel models as a categorical covariate (underweight, normal weight, overweight, obese) 
with normal weight as the reference category. A main effect term was included for BMI and 
also interactions with each of the spline variables. Reference ranges by smoking status were 
produced similarly, by entering smoking status as a categorical covariate (never smoked, 
smoked pre-pregnancy/1
st
 trimester, smoked throughout pregnancy), with never smoked as 
the reference category, as a main effect and also as interactions with each of the splines. The 
between and within-individual variances were calculated in the same way as for the 
unadjusted model. Separate multilevel models were fitted for nulliparous and multiparous 
women. 
For the reference ranges which were conditional on SBP or DBP at 12 weeks gestation we 
used the unadjusted multilevel models as above, fitted only for the low-risk group (normal 
BMI; non-smokers) of women who had normal pregnancies. We obtained conditional 
predictions from this using the method described by Tilling et al[4] and Pan and Goldstein.[5] 
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The covariance between the deviations from the predicted curve at 12 weeks and g weeks is 
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Therefore, the predicted SBP or DBP at gestational age g, conditional on the value at 12 
weeks gestation is: 
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Where y12 is the observed value of the outcome (either SBP or DBP) at 12 weeks gestation, 
Vb12 is the between-individual variance in the outcome at 12 weeks and Vw12 is the within-
individual variance. Thus, the deviation of the 12-week measurement from the average 
trajectory was combined with the multilevel model information to predict what trajectory 
would be seen for the rest of gestation. Conditional predictions were produced for 
hypothetical SBP values of 100, 110, 120 and 130 mmHg and DBP values of 50, 60, 70 and 
80 mmHg at 12 weeks gestation. 
The variance of this prediction is 
)(
)(
1212
2
,12
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wgbg
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V
VV

  and is used to calculate the 
reference ranges. 
We tested the fit of the reference ranges conditional on the value of blood pressure at 12 
weeks to the measurements in this cohort, by comparing predicted reference ranges 
conditional on each individual’s blood pressure measurement at (or within 3 weeks either 
side of) 12 weeks gestation against their actual blood pressure measurements from 16 weeks 
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onwards. The 95% reference ranges for SBP conditional on blood pressure at 12 weeks 
contained 94.5% of actual blood pressure measurements from 16 weeks gestation onwards 
for nulliparous women and 94.8% of actual blood pressure measurements for multiparous 
women. The 95% reference ranges for DBP conditional on blood pressure at 12 weeks 
contained 95.2% of actual blood pressure measurements for nulliparous women, and 94.6% 
for multiparous women.
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Please note, the following 4 tables are part of the Supplemental Methods and are not referred 
to in the main text. Thus, they have been labelled as Table X, rather than Web-Table X. 
 
Table 1 Model fit for low-risk SBP model in nulliparous women 
 
*
 The range within which 90% of differences between the observed and model predicted values lie.
Gestational 
period 
(weeks) 
Number of 
measurements 
Observed 
SBP 
Mean (SD) 
Predicted 
SBP 
Mean (SD) 
Observed – 
Predicted SBP 
Mean (SD) 
90% Limits of 
Agreement
* 
Up to 8 192 112.5 (12.83) 113.5 (6.07) -1.03 (9.21) (-13.94, 13.91) 
9 - 10 420 111.3 (11.52) 112.0 (5.96) -0.73 (7.97) (-14.56, 12.20) 
11 – 12 739 112.4 (11.37) 112.5 (6.13) -0.08 (8.33) (-13.83, 13.95) 
13 – 14 817 112.4 (11.96) 111.4 (6.49) 1.04 (8.70) (-12.76, 15.16) 
15 – 16 699 112.4 (11.77) 111.7 (6.61) 0.67 (8.34) (-13.12, 14.42) 
17 – 18 1062 110.9 (12.01) 111.3 (7.01) -0.46 (8.13) (-14.42, 13.24) 
19 – 20 729 110.8 (11.31) 111.2 (6.93) -0.38 (7.63) (-12.68, 13.06) 
21 – 22 924 110.9 (11.16) 111.3 (7.04) -0.35 (7.36) (-12.48, 11.69) 
23 – 24 761 111.9 (11.53) 111.8 (7.30) 0.13 (7.52) (-11.80, 13.30) 
25 – 26 930 112.2 (11.12) 112.0 (7.37) 0.18 (7.01) (-11.56, 11.37) 
27 – 28 962 112.8 (11.27) 112.6 (7.17) 0.20 (7.13) (-10.89, 12.21) 
29 – 30 1343 112.8 (11.31) 112.7 (7.35) 0.05 (7.32) (-11.30, 11.89) 
31 – 32 1452 112.9 (11.35) 112.9 (7.15) 0.02 (7.58) (-12.02, 12.00) 
33 – 34 1588 112.8 (11.14) 113.2 (6.94) -0.44 (7.76) (-12.32, 11.92) 
35 – 36 1551 114.2 (11.68) 114.1 (7.15) 0.12 (8.10) (-12.74, 13.09) 
37 – 38 1954 115.8 (12.38) 115.5 (7.32) 0.34 (8.27) (-11.66, 13.87) 
39 – 40 1649 117.4 (12.66) 117.5 (7.51) -0.17 (8.21) (-13.11, 14.02) 
41+ 851 119.4 (12.77) 119.5 (7.78) -0.12 (8.09) (-13.43, 12.67) 
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Table 2 Model fit for low-risk DBP model in nulliparous women 
 
*
 The range within which 90% of differences between the observed and model predicted values lie.
Gestational 
period 
(weeks) 
Number of 
measurements 
Observed 
DBP 
Mean (SD) 
Predicted 
DBP 
Mean (SD) 
Observed – 
Predicted DBP 
Mean (SD) 
90% Limits of 
Agreement
* 
Up to 8 192 66.5 (9.15) 67.0 (3.78) -0.48 (7.38) (-12.55, 9.73) 
9 - 10 420 65.2 (7.81) 65.8 (3.53) -0.64 (6.20) (-10.74, 10.16) 
11 – 12 739 66.0 (8.23) 65.8 (3.79) 0.22 (6.46) (-10.31, 10.66) 
13 – 14 817 65.7 (8.13) 65.3 (3.83) 0.42 (6.41) (-10.19, 11.15) 
15 – 16 699 65.3 (7.98) 65.1 (3.95) 0.27 (6.13) (-9.42, 10.56) 
17 – 18 1062 64.5 (8.11) 64.6 (4.02) -0.12 (6.07) (-10.07, 10.19) 
19 – 20 729 64.5 (7.74) 64.6 (4.09) -0.18 (5.60) (-9.74, 9.01) 
21 – 22 924 64.2 (7.67) 64.6 (4.23) -0.33 (5.55) (-9.05, 8.77) 
23 – 24 761 65.2 (7.98) 64.9 (4.20) 0.31 (5.78) (-9.68, 9.45) 
25 – 26 930 65.0 (7.73) 65.0 (4.33) 0.03 (5.61) (-8.94, 9.39) 
27 – 28 962 65.4 (8.07) 65.5 (4.56) -0.10 (5.47) (-8.72, 8.82) 
29 – 30 1343 66.0 (7.77) 65.8 (4.52) 0.16 (5.46) (-8.44, 9.20) 
31 – 32 1452 66.1 (7.93) 66.2 (4.62) -0.13 (5.67) (-9.63, 8.90) 
33 – 34 1588 66.7 (8.29) 66.8 (4.66) -0.12 (6.02) (-9.29, 9.54) 
35 – 36 1551 68.2 (8.64) 68.0 (5.08) 0.16 (6.00) (-9.47, 10.58) 
37 – 38 1954 70.0 (9.17) 69.9 (5.34) 0.13 (6.22) (-9.99, 10.48) 
39 – 40 1649 72.0 (9.89) 72.3 (5.67) -0.31 (6.41) (-10.23, 10.56) 
41+ 851 74.6 (10.11) 74.4 (6.16) 0.25 (6.35) (-10.04, 10.52) 
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Table 3 Model fit for low-risk SBP model in multiparous women 
 
*
 The range within which 90% of differences between the observed and model predicted values lie.
Gestational 
period 
(weeks) 
Number of 
measurements 
Observed 
SBP 
Mean (SD) 
Predicted 
SBP 
Mean (SD) 
Observed – 
Predicted SBP 
Mean (SD) 
90% Limits of 
Agreement
* 
Up to 8 215 110.7 (10.35) 111.9 (5.37) -1.18 (7.73) (-14.12, 11.20) 
9 - 10 505 110.3 (11.62) 110.5 (5.53) -0.16 (8.36) (-13.52, 12.39) 
11 – 12 821 110.6 (11.34) 110.5 (6.01) 0.08 (8.12) (-13.45, 13.66) 
13 – 14 985 110.8 (11.58) 109.9 (5.96) 0.89 (8.50) (-12.79, 15.55) 
15 – 16 839 109.5 (11.51) 109.7 (6.24) -0.19 (7.92) (-12.98, 13.10) 
17 – 18 1257 108.9 (11.32) 109.5 (6.39) -0.59 (7.95) (-13.89, 12.92) 
19 – 20 858 109.3 (10.78) 109.3 (6.28) -0.01 (7.66) (-12.48, 12.39) 
21 – 22 1062 109.8 (11.48) 109.6 (6.95) 0.25 (7.49) (-12.29, 11.77) 
23 – 24 916 110.3 (10.55) 110.1 (6.73) 0.22 (7.28) (-12.30, 11.27) 
25 – 26 1080 110.2 (11.62) 110.4 (7.11) -0.19 (7.53) (-12.61, 12.55) 
27 – 28 1101 110.7 (11.17) 110.6 (7.14) 0.15 (7.23) (-10.98, 12.20) 
29 – 30 1569 111.0 (11.19) 111.1 (7.05) -0.13 (7.12) (-11.75, 11.43) 
31 – 32 1642 111.4 (11.29) 111.4 (7.05) 0.01 (7.47) (-11.49, 12.27) 
33 – 34 1839 111.7 (11.42) 111.6 (6.98) 0.13 (7.87) (-12.15, 13.64) 
35 – 36 1805 112.3 (11.28) 112.4 (6.91) -0.05 (7.73) (-12.48, 12.01) 
37 – 38 2213 113.5 (11.39) 113.5 (6.73) -0.02 (7.68) (-12.26, 13.20) 
39 – 40 2015 115.0 (12.12) 115.1 (7.00) -0.09 (7.91) (-12.50, 13.20) 
41+ 821 116.6 (11.90) 116.5 (6.78) 0.15 (8.01) (-11.79, 13.85) 
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Table 4 Model fit for low-risk DBP model in multiparous women 
 
*
 The range within which 90% of differences between the observed and model predicted values lie.  
Gestational 
period 
(weeks) 
Number of 
measurements 
Observed 
DBP 
Mean (SD) 
Predicted 
DBP 
Mean (SD) 
Observed – 
Predicted DBP 
Mean (SD) 
90% Limits of 
Agreement
* 
Up to 8 215 65.8 (7.52) 66.1 (3.19) -0.30 (6.39) (-10.05, 11.76) 
9 - 10 505 65.0 (8.60) 65.3 (3.43) -0.25 (6.55) (-10.65, 10.89) 
11 – 12 821 65.2 (7.87) 64.9 (3.61) 0.32 (6.17) (-9.77, 10.57) 
13 – 14 985 64.6 (7.69)     64.4 (3.64) 0.16 (6.12) (-10.27, 10.30) 
15 – 16 839 64.0 (7.95) 64.1 (3.90) -0.08 (5.96) (-9.50, 10.30) 
17 – 18 1257 63.4 (7.90) 63.7 (4.13) -0.37 (5.83) (-10.06, 9.42) 
19 – 20 858 63.6 (7.82) 63.6 (4.10) 0.06 (5.63) (-8.94, 9.41) 
21 – 22 1062 63.8 (7.81) 63.7 (4.35) 0.10 (5.48) (-8.62, 9.34) 
23 – 24 916 64.3 (7.64) 63.9 (4.22) 0.33 (5.60) (-8.88, 9.12) 
25 – 26 1080 63.9 (7.84) 64.0 (4.40) -0.07 (5.54) (-8.66, 9.30) 
27 – 28 1101 64.4 (7.84) 64.3 (4.41) 0.04 (5.33) (-8.38, 9.33) 
29 – 30 1569 64.7 (7.83) 64.7 (4.32) -0.05 (5.46) (-8.88, 9.05) 
31 – 32 1642 65.1 (7.75) 65.1 (4.42) -0.04 (5.53) (-8.99, 8.73) 
33 – 34 1839 65.5 (7.89) 65.6 (4.45) -0.08 (5.69) (-9.06, 9.50) 
35 – 36 1805 66.6 (8.41) 66.5 (4.55) 0.07 (5.98) (-9.29, 10.39) 
37 – 38 2213 68.1 (8.82) 68.0 (4.75) 0.11 (6.14) (-9.40, 10.47) 
39 – 40 2015 69.6 (9.22) 69.7 (4.92) -0.15 (6.36) (-10.13, 10.47) 
41+ 821 71.6 (9.66) 71.5 (5.11) 0.09 (6.47) (-9.91, 10.90) 
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 Web-Table 1 List of all subgroups of women for whom reference ranges have been developed
* 
*
 Each row represents a subgroup of women for whom a reference range is presented in this paper. Cells 
marked with – indicate that this characteristic was not part of the criteria for defining the subgroup for 
this particular reference range
 Reference 
Range Group 
Parity Pre-pregnancy 
BMI 
Smoking during 
pregnancy 
Blood pressure at 12 
weeks (mmHg) 
All pregnancies 
(Figure 1) 
Nulliparous - - - 
Multiparous - - - 
N
o
rm
a
l 
p
re
g
n
a
n
ci
es
 
All normal 
pregnancies 
(Figure 1) 
Nulliparous - - - 
Multiparous - - - 
Low-risk 
women  
(Figure 2) 
Nulliparous Normal weight Never smoked - 
Multiparous Normal weight Never smoked - 
High-risk 
women  
(Figure 2) 
Nulliparous Overweight/Obese Any smoking  - 
Multiparous Overweight/Obese Any smoking  - 
Reference 
ranges by pre-
pregnancy BMI 
category  
(Figure 3 and 
Web-Figure 1) 
 
Nulliparous Underweight Never smoked - 
Nulliparous Normal weight Never smoked - 
Nulliparous Overweight Never smoked - 
Nulliparous Obese Never smoked - 
Multiparous Underweight Never smoked - 
Multiparous Normal weight Never smoked - 
Multiparous Overweight Never smoked - 
Multiparous Obese Never smoked - 
Reference 
ranges by 
smoking during 
pregnancy 
(Figure 4 and 
Web-Figure 4) 
 
Nulliparous Normal weight Never smoked - 
Nulliparous Normal weight Pre-pregnancy/1
st
 
trimester only 
- 
Nulliparous Normal weight Throughout  - 
Multiparous Normal weight Never smoked - 
Multiparous Normal weight Pre-pregnancy/1
st
 
trimester only 
- 
Multiparous Normal weight Throughout  - 
Reference 
ranges 
conditional on 
blood pressure 
at 12 weeks 
(Figure 5 and 
Web-Figure 7) 
 
Nulliparous Normal weight Never smoked SBP = 100 at 12 weeks 
Nulliparous Normal weight Never smoked SBP = 110 at 12 weeks 
Nulliparous Normal weight Never smoked SBP = 120 at 12 weeks 
Nulliparous Normal weight Never smoked SBP = 130 at 12 weeks 
Nulliparous Normal weight Never smoked DBP = 50 at 12 weeks 
Nulliparous Normal weight Never smoked DBP = 60 at 12 weeks 
Nulliparous Normal weight Never smoked DBP = 70 at 12 weeks 
Nulliparous Normal weight Never smoked DBP = 80 at 12 weeks 
Multiparous Normal weight Never smoked SBP = 100 at 12 weeks 
Multiparous Normal weight Never smoked SBP = 110 at 12 weeks 
Multiparous Normal weight Never smoked SBP = 120 at 12 weeks 
Multiparous Normal weight Never smoked SBP = 130 at 12 weeks 
Multiparous Normal weight Never smoked DBP = 50 at 12 weeks 
Multiparous Normal weight Never smoked DBP = 60 at 12 weeks 
Multiparous Normal weight Never smoked DBP = 70 at 12 weeks 
Multiparous Normal weight Never smoked DBP = 80 at 12 weeks 
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Web-Table 2 Mean and 95% reference ranges for systolic and diastolic blood pressure at three gestational ages across pregnancy for 
different subgroups of women from multilevel models 
Maternal Subgroup 
N Mean (95% reference range) 
SBP at 12 
weeks 
SBP at 20 
weeks 
SBP at 37 
weeks 
DBP at 12 
weeks 
DBP at 20 
weeks 
DBP at 37 
weeks 
All women 
(Figure 1) 
Nulliparous 4718 112.7 
(88.6, 136.8) 
112.4 
(88.9, 135.9) 
117.2 
(91.6, 142.8) 
65.9 
(48.9, 82.9) 
65.1 
(48.9, 81.2) 
71.2 
(51.3, 91.2) 
Multiparous 5609 111.6 
(88.2, 135.0) 
111.0 
(87.7, 134.3) 
115.0 
(90.6, 139.3) 
65.5 
(48.9, 82.1) 
64.4 
(48.4, 80.5) 
68.8 
(50.3, 87.2) 
N
o
rm
a
l 
p
re
g
n
a
n
ci
es
*
 
All normal 
pregnancies 
(Figure 1) 
Nulliparous 3372 112.1 
(88.6, 135.5) 
111.9 
(89.4, 134.4) 
116.0 
(92.3, 139.7) 
65.4 
(48.9, 81.9) 
64.6 
(49.2, 80.1) 
70.0 
(52.2, 87.9) 
Multiparous 4132 111.0 
(88.1, 133.9) 
110.3 
(87.8, 132.8) 
114.2 
(91.0, 137.4) 
65.1 
(49.0, 81.1) 
64.0 
(48.4, 79.6) 
68.2 
(51.0, 85.3) 
Low-risk 
(normal BMI, 
non-smokers) 
(Figure 2) 
Nulliparous 
 
1832 112.0 
(88.9, 135.0) 
111.3 
(89.0, 133.5) 
115.4 
(92.0, 138.8) 
65.6 
(49.5, 81.7) 
64.6 
(49.4, 79.8) 
69.9 
(52.0, 87.8) 
Multiparous 2193 110.2 
(88.0, 132.5) 
109.4 
(87.6, 131.2) 
113.5 
(90.6, 136.4) 
64.7 
(49.2, 80.3) 
63.6 
(48.4, 78.8) 
67.9 
(50.8, 85.0) 
High-risk 
(overweight/ 
obese, any 
smoking) 
(Figure 2) 
Nulliparous 205 114.7 
(89.4, 139.9) 
115.9 
(94.3, 137.4) 
119.2 
(95.5, 143.0) 
67.0 
(49.4, 84.7) 
66.7 
(50.2, 83.1) 
72.2 
(54.0, 90.4) 
Multiparous 285 114.3  
(91.0, 137.6) 
113.2 
(90.4, 136.0) 
117.6 
(94.9, 140.3) 
66.9 
(50.6, 83.3) 
65.4 
(49.3, 81.6) 
69.5 
(52.1, 86.9) 
By BMI (non-
smokers only) 
Nulliparous 
(Figure 3) 
Underweight 97 109.5 
(86.4, 132.5) 
110.6 
(88.3, 132.8) 
113.6 
(90.1, 137.2) 
64.2 
(48.1, 80.3) 
63.4 
(48.2, 78.6) 
68.3 
(50.5, 86.2) 
Normal 1832 112.0  
(89.0, 135.0) 
111.3 
(89.0, 133.5) 
115.4 
(91.9, 138.9) 
65.6 
(49.5, 81.6) 
64.6 
(49.4, 79.8) 
69.9 
(52.1, 87.7) 
Overweight 275 115.9  
(92.8, 138.9) 
116.0 
(93.8, 138.2) 
119.8 
(96.3, 143.3) 
68.4 
(52.3, 84.4) 
68.2 
(53.0, 83.4) 
73.2 
(55.4, 91.1) 
Obese 66 121.9 
(98.8, 144.9) 
122.0 
(99.8, 144.3) 
125.7 
(102.2, 149.3) 
73.1 
(57.0, 89.2) 
71.4 
(56.2, 86.6) 
77.8 
(60.0, 95.6) 
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*
 Normal pregnancies are defined as those where the woman did not have essential hypertension or preeclampsia, pre-existing or gestational 
diabetes and the pregnancy resulted and gave birth to an appropriate-size-for-gestational-age baby at term
Maternal Subgroup 
N Mean (95% reference range) 
SBP at 12 
weeks 
SBP at 20 
weeks 
SBP at 37 
weeks 
DBP at 12 
weeks 
DBP at 20 
weeks 
DBP at 37 
weeks 
N
o
rm
a
l 
p
re
g
n
a
n
ci
es
*
 
By BMI (non-
smokers only) 
Multiparous 
(Web-
Figure 1) 
Underweight 122 107.9 
(85.4, 130.4) 
106.4 
(84.4, 128.5) 
110.3 
(87.4, 133.2) 
64.0 
(48.4, 79.6) 
62.4 
(47.3, 77.6) 
66.2 
(49.1, 83.4) 
Normal 2193 110.2 
(87.7, 132.7) 
109.4 
(87.4, 131.4) 
113.5 
(90.6, 136.4) 
64.7 
(49.1, 80.3) 
63.6 
(48.5, 78.8) 
67.9 
(50.8, 85.1) 
Overweight 430 115.1 
(92.6, 137.5) 
114.2 
(92.2, 136.2) 
117.0 
(94.1, 139.9) 
67.8 
(52.2, 83.4) 
67.1 
(52.0, 82.3) 
70.3 
(53.1, 87.5) 
Obese 161 117.9 
(95.4, 140.4) 
118.1 
(96.0, 140.1) 
121.4 
(98.5, 144.3) 
70.7 
(55.1, 86.3) 
69.7 
(54.6, 84.9) 
74.3 
(57.2, 91.5) 
By smoking in 
pregnancy 
(normal weight 
women only) 
Nulliparous 
(Figure 4) 
Never 
smoked 
1832 112.0 
(89.1, 134.9) 
111.3 
(89.2, 133.3) 
115.4 
(91.9, 138.9) 
65.6 
(49.6, 81.5) 
64.6 
(49.6, 79.6) 
69.9 
(52.5, 87.2) 
1
st
 trimester 443 110.4 
(87.5, 133.3) 
110.5 
(88.4, 132.6) 
115.5 
(92.0, 139.0) 
63.8 
(47.9, 79.8) 
63.3 
(48.3, 78.3) 
69.0 
(51.6, 86.3) 
Throughout  379 110.4 
(87.5, 133.3) 
110.9 
(88.8, 133.0) 
114.4 
(90.9, 137.9) 
63.3 
(47.3, 79.2) 
62.6 
(47.6, 77.6) 
68.1 
(50.7, 85.5) 
Multiparous 
(Web-
Figure 4) 
Never 
smoked 
2193 110.2 
(88.1, 132.4) 
109.4 
(87.6, 131.2) 
113.5 
(90.5, 136.4) 
64.7 
(49.1, 80.3) 
63.6 
(48.5, 78.7) 
67.9 
(51.1, 84.7) 
1
st
 trimester 302 109.0 
(86.8, 131.1) 
108.6 
(86.8, 130.3) 
112.6 
(89.6, 135.5) 
63.4 
(47.8, 79.0) 
62.7 
(47.6, 77.8) 
67.1 
(50.2, 83.9) 
Throughout  554 109.8 
(87.6, 131.9) 
109.3 
(87.5, 131.1) 
113.3 
(90.3, 136.2) 
63.3 
(47.7, 78.9) 
62.3 
(47.2, 77.4) 
66.4 
(49.5, 83.2) 
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Web-Table 3 Mean and 95% reference ranges for predicted systolic and diastolic blood pressure at 20 weeks and 37 weeks in normal 
pregnancies for normal weight non-smoking women conditional on hypothetical measurements of SBP and DBP at 12 weeks gestation 
from multilevel models 
 
 Error prone 
measurement 
of SBP at 12 
weeks (mmHg) 
Mean (95% reference range) SBP 
prediction 
Error prone 
measurement 
of DBP at 12 
weeks (mmHg) 
Mean (95% reference range) DBP 
prediction 
20 weeks 37 weeks 20 weeks 37 weeks 
Nulliparous 
women 
(Figure 5) 
100 106.7 
(86.2, 127.2) 
111.9 
(89.5, 134.4) 
50 59.7 
(45.4, 74.1) 
66.2 
(48.7, 83.7) 
110 110.5 
(90.0, 131.0) 
114.8 
(92.4, 137.3) 
60 62.9 
(48.5, 77.2) 
68.6 
(51.1, 86.0) 
120 114.3 
(93.8, 134.8) 
117.8 
(95.3, 140.2) 
70 66.0 
(51.6, 80.3) 
70.9 
(53.5, 88.4) 
130 118.1 
(97.6, 138.6) 
120.7 
(98.2, 143.1) 
80 69.1 
(54.7, 83.4) 
73.3 
(55.8, 90.8) 
Multiparous 
women 
(Web- 
Figure 7) 
100 105.6 
(85.4, 125.8) 
110.5 
(88.5, 132.5) 
50 59.0 
(44.7, 73.4) 
64.1 
(47.5, 80.6) 
110 109.3 
(89.1, 129.5) 
113.4 
(91.4, 135.4) 
60 62.1 
(47.8, 76.5) 
66.7 
(50.1, 83.3) 
120 113.0 
(92.8, 133.2) 
116.3 
(94.3, 138.3) 
70 65.2 
(50.9, 79.6) 
69.3 
(52.7, 85.9) 
130 116.7 
(96.5, 136.9) 
119.1 
(97.1, 141.1) 
80 68.4 
(54.0, 82.7) 
71.9 
(55.3, 88.5) 
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Web-Figure 1 Reference ranges for systolic and diastolic blood pressure by maternal 
pre-pregnancy BMI category for multiparous non-smokers with normal pregnancies 
(N=2906) 
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Web-Figure 2 Average trajectories of systolic blood pressure by maternal pre-pregnancy BMI category in a) nulliparous and b) 
multiparous non-smoking women with normal pregnancies 
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Web-Figure 3 Average trajectories of diastolic blood pressure by maternal pre-pregnancy BMI category in a) nulliparous and b) 
multiparous non-smoking women with normal pregnancies 
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Web-Figure 4 Reference ranges for systolic and diastolic blood pressure by maternal smoking during pregnancy for multiparous 
normal-weight women with normal pregnancies (N=3049) 
 
20 
 
Web-Figure 5 Average trajectories of systolic blood pressure by maternal smoking in pregnancy in a) nulliparous and b) multiparous 
normal weight women with normal pregnancies 
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Web-Figure 6 Average trajectories of diastolic blood pressure by maternal smoking in pregnancy in a) nulliparous and b) multiparous 
normal weight women with normal pregnancies 
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Web-Figure 7 Reference ranges for systolic and diastolic blood pressure in pregnancy conditional on the level of blood pressure at 12 
weeks gestation for multiparous normal-weight non-smoking women with normal pregnancies (N=2193)
* 
 
*
 Note that in each of the plots there is a star that corresponds to the value of SBP/DBP at 12 weeks. 
